Leef Brands (TSE:LEEF)
:LEEF
Want to see TSE:LEEF full AI Analyst Report?
Top Page
Leef Brands
(LEEF)
Select Model
Select Model
Rating:45Neutral
Price Target:
C$0.24
▼(-14.64% Downside)
Action:Reiterated
Date:04/23/26
The score is primarily held down by weak financial performance—persistent large losses, negative equity, and negative free cash flow despite improving revenue. Technicals are mixed with limited momentum, and valuation is constrained by a negative P/E and no dividend support.
Positive Factors
Revenue Growth
Sustained top-line growth to ~$34.8M TTM shows the company is gaining distribution and market traction in regulated channels. Durable revenue expansion supports operational scale, helps absorb fixed costs, and provides a runway to invest in manufacturing and go-to-market capabilities over the next 2–6 months.
Negative Factors
Deep Net Losses & Negative Equity
Very large net losses and negative shareholders' equity reflect accumulated deficits and weaken the company’s capital cushion. This structural weakness limits strategic flexibility, raises dilution risk from future capital raises, and complicates lender confidence and long-term solvency assessments.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained top-line growth to ~$34.8M TTM shows the company is gaining distribution and market traction in regulated channels. Durable revenue expansion supports operational scale, helps absorb fixed costs, and provides a runway to invest in manufacturing and go-to-market capabilities over the next 2–6 months.
Read all positive factors
Leef Brands (LEEF) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$57.47M
Dividend YieldN/A
Average Volume (3M)144.57K
Price to Earnings (P/E)―
Beta (1Y)-0.22
Revenue GrowthN/A
EPS GrowthN/A
CountryCA
Employees72
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.08
Shares Outstanding280,358,370
10 Day Avg. Volume233,994
30 Day Avg. Volume144,567
Financial Highlights & Ratios
PEG Ratio-0.23
Price to Book (P/B)-2.68
Price to Sales (P/S)1.14
P/FCF Ratio-4.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Leef Brands Business Overview & Revenue Model
Company Description
Leef Brands Inc. operates as a cannabis branded products manufacturer in the United States. The company operates in two segments: Wholesale Concentrates and Retail. It is involved in the propagation, nursery, flowering canopy, drying, processing, ...
How the Company Makes Money
Leef Brands primarily makes money by selling cannabis products it manufactures into regulated cannabis markets. Revenue is generated through wholesale distribution of its packaged products to licensed dispensaries/retailers and other permitted can...
Leef Brands Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
16
Very Negative
| Breakdown | Dec 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Jul 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 30.75M | 28.50M | 30.61M | 27.00M | 7.85M |
| Gross Profit | 7.62M | 8.94M | 10.02M | 9.55M | 2.16M |
| EBITDA | -17.43M | -14.26M | -33.41M | -18.89M | ― |
| Net Income | -26.13M | -24.62M | -34.97M | -28.92M | ― |
Balance Sheet | |||||
| Total Assets | 41.27M | 42.98M | 44.00M | 61.93M | 47.12M |
| Cash, Cash Equivalents and Short-Term Investments | 887.89K | 2.73M | 6.41M | 3.31M | 1.45M |
| Total Debt | 24.14M | 23.15M | 20.38M | 10.91M | 1.33M |
| Total Liabilities | 54.35M | 55.41M | 43.15M | 34.19M | 10.13M |
| Stockholders Equity | -13.08M | -12.43M | -2.80M | 23.94M | 36.99M |
Cash Flow | |||||
| Free Cash Flow | -7.43M | -7.32M | -7.42M | -6.44M | -2.09M |
| Operating Cash Flow | -4.01M | -1.05M | 187.82K | -6.32M | -710.62K |
| Investing Cash Flow | -3.01M | -6.27M | -7.28M | 2.23M | -1.97M |
| Financing Cash Flow | 4.76M | 3.63M | 10.38M | 49.69K | 2.56M |
Leef Brands Technical Analysis
Negative
0.28
Price Trends
0.23
Negative
0.21
Negative
0.24
Negative
Market Momentum
>-0.01
Positive
43.73
Neutral
25.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LEEF, the sentiment is Negative. The current price of 0.28 is above the 20-day moving average (MA) of 0.22, above the 50-day MA of 0.23, and above the 200-day MA of 0.24, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 43.73 is Neutral, neither overbought nor oversold. The STOCH value of 25.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LEEF.
Leef Brands Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | C$133.80M | -1.83 | 66.16% | ― | 3.04% | -47.28% | |
46 Neutral | C$94.76M | -2.23 | -275.39% | ― | -2.64% | -36.69% | |
46 Neutral | C$60.79M | -1.55 | -112.30% | ― | -21.09% | -54.32% | |
45 Neutral | C$57.47M | -0.85 | 136.59% | ― | ― | ― | |
40 Neutral | C$18.10M | -0.04 | ― | ― | ― | ― |
* Healthcare Sector Average
TSE:LEEF
Leef Brands
0.21
-0.04
-16.33%
TSE:JUSH
Jushi Holdings
0.67
0.21
45.65%
TSE:CWEB
Charlotte's Web Holdings
0.59
0.47
391.67%
TSE:AYR.A
Ayr Wellness
0.16
-0.17
-52.31%
TSE:PLTH
Planet 13 Holdings
0.19
-0.16
-46.38%
Leef Brands Corporate Events
Business Operations and StrategyExecutive/Board ChangesPrivate Placements and Financing
LEEF Brands Secures US$4.5 Million to Expand Flagship Cannabis Farm and Adds Industry Veteran to Board
Positive
Mar 13, 2026
LEEF Brands has secured an initial US$4.5 million tranche of up to US$8 million in non-brokered private placement financing led by Mindset Capital, issuing common and preferred shares to fund the expansion of its Salisbury Canyon Ranch cultivation...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.